
Sign up to save your podcasts
Or


A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse.
Click for transcript
By Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more4.4
1818 ratings
A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse.
Click for transcript

32,238 Listeners

538 Listeners

752 Listeners

125 Listeners

338 Listeners

61 Listeners

86 Listeners

35 Listeners

152 Listeners

64 Listeners

16 Listeners

12 Listeners

15 Listeners

8 Listeners

60 Listeners